Chronic Pain Clinical Trials Conditions Media 
The Blunt Truth
FEBRUARY 17, 2023
MEDICAL MARIJUANA FOR VETS Could veterans suffering from PTSD or chronic pain be able to use cannabis to relieve their symptoms? The company is the first social media platform to permit such ads , and they come with many restrictions on type of content. We have an update on those SAFE Banking talks.
Cannabis Law Report
SEPTEMBER 13, 2021
(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. Media: media@mymd.com. in the blood. 646) 421-9523.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
FloridaMarijuana.net
JUNE 13, 2018
Mainstream media has begun to illustrate just how effective medical marijuana can be in helping cancer patients. As the skin absorbs the pain-relieving compounds, the pain is blocked, but without affecting other parts of your body. Newsweek Magazine labeled marijuana the “wonder drug when it comes to the horrors of chemo.”
Cannabis Law Report
JANUARY 12, 2022
. “Gb Sciences has established a pipeline of patent-protected combination therapies for the treatment of medical conditions affecting hundreds of millions of people,” said Dr. Andrea Small-Howard, President and Chief Science Officer of Gb Sciences. Media Contact. In addition, Gb Sciences has 12 U.S. 31, 2021.
Cannabis Law Report
OCTOBER 5, 2021
The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy. Media: media@mymd.com. MYMD-1 is being developed to delay aging, increase longevity, and treat autoimmune diseases and COVID-19- associated depression. Investor: Robert Schatz. 646) 421-9523.
MMJ Recs
DECEMBER 22, 2023
Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. One significant factor is the recognition of the opioid crisis and the need for alternative pain management strategies.
Cannabis Law Report
SEPTEMBER 22, 2021
At 8,000 times the potency of regular CBD, we believe that Supera-CBD shows strong potential as a therapeutic for high-threat diseases and conditions like Alzheimer’s, psychosis, neuropathic pain, addiction, and anxiety. Media Contact: media@mymd.com. Chris Chapman, M.D., About MyMD Pharmaceuticals, Inc.
Expert insights. Personalized for you.
96 
Let's personalize your content